PolyMedix, Inc. Report issue

For profit Phase 2
Founded: Radnor PA United States (2002)
Status: Acquired by Innovation Pharmaceuticals (2013)

Organization Overview

First Clinical Trial
2010
NCT01211470
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 2 Trials (3)

brilacidin (1 trial)

daptomycin (cubicin) (1 trial)

pmx-60056 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Communicable Diseases (Phase 2)

Coronary Artery Disease (Phase 2)

Infections (Phase 2)

Skin Diseases, Bacterial (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 3